Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Erin Yu"'
Autor:
Christian Pino, Matthew W. Lee, Zachary S. Anderson, Aaron D. Masjedi, Erin Yu, Katelyn B. Furey, Laila I. Muderspach, Lynda D. Roman, Jason D. Wright, Koji Matsuo
Publikováno v:
Gynecologic Oncology Reports, Vol 54, Iss , Pp 101455- (2024)
In this retrospective cohort study examining 13,763,447 patients with 16 different malignancies, including 1,232,841 patients with five gynecologic malignancies (uterus [n = 690,590], ovary [n = 276,812], cervix [n = 166,779], vulva [n = 81,575], and
Externí odkaz:
https://doaj.org/article/f299985057bc47d28424e34eb6a34cb0
Autor:
Ning Xu, Erin Yu, Nicole Ng, Mingjie Li, Sean Bujarski, Ava Hekmati, Isabella Nassir, Tara Hekmati, Janna Yu, David Daniely, Cathy S. Wang, Clara Kim, Haiming Chen, James R. Berenson
Publikováno v:
Hematological oncologyREFERENCES.
We hypothesized that ruxolitinib may inhibit the immune checkpoint protein, B7H3; and, thus, investigated its effects on this immune inhibitor using multiple myeloma (MM) cell lines, bone marrow (BM) mononuclear cells from MM patients and human MM LA
Autor:
Nithya D. Rajeev, Jamil S. Samaan, Agnes Premkumar, Nitin Srinivasan, Erin Yu, Kamran Samakar
Publikováno v:
The Journal of surgical research. 283
Bariatric surgery is an effective therapeutic modality for obesity and related comorbidities, yet it remains significantly underutilized. Patient perceptions and expectations may influence the decisions of eligible patients in pursuing surgery.PubMed
Autor:
Erin Yu, Jessica R. Chang
Publikováno v:
Frontiers in Ophthalmology. 2
Giant cell arteritis (GCA) is a systemic granulomatous vasculitis affecting the medium and large-size arteries, and may present with a range of ophthalmic findings. This review will cover GCA epidemiology, pathophysiology, clinical presentation, diag
Autor:
Haiming Chen, Tanya M. Spektor, Nicole Ng, Janna Yu, James R. Berenson, Mingjie Li, Justin Huang, Cathy Wang, David Daniely, Zhengyi Yin, Sean Bujarski, Isabella Nassir, Ning Xu, Mingxiang Wen, Tara Hekmati, Dylan Field, Jasper Wang, Erin Yu
Publikováno v:
British journal of haematologyReferences. 192(3)
Multiple myeloma (MM) tumour cells evade host immunity through a variety of mechanisms, which may potentially include the programmed cell death ligand-1 (PD-L1):programmed cell death protein-1 (PD-1) axis. This interaction contributes to the immunosu
Publikováno v:
Circulation Research. 125
Background: The aging heart is prone to diseases and injuries, and is associated with changes in gene expression and alternative splicing. The goal of our study is to identify changes in protein isoforms in cardiac aging and explore their roles in ag
Autor:
Tara Hekmati, Dylan Field, Isabella Nassir, David Daniely, Haiming Chen, Eric Sanchez, Mingjie Li, James R. Berenson, Sean Bujarski, Nicole Ng, Cathy Wang, Ning Xu, Erin Yu, Justin Huang, Janna Yu, Jasper Wang, Zhengyi Yin
Publikováno v:
Blood. 134:4402-4402
Introduction: Multiple myeloma (MM) tumor cells evade host immunity through the interaction of PD-L1 and PD-L2 to PD-1 on T-cells. This creates an immunosuppressive milieu in the bone marrow (BM) microenvironment. The immune inhibitory proteins PD-L1
Autor:
Jasper Wang, Haiming Chen, Mingjie Li, Erin Yu, Nicole Ng, Tara Hekmati, Cathy Wang, Zhengyi Yin, Justin Huang, Dylan Field, Sean Bujarski, Janna Yu, Ning Xu, Eric Sanchez, James R. Berenson, Isabella Nassir, David Daniely
Publikováno v:
Blood. 134:1824-1824
Introduction: The JAKSTAT pathway plays a critical role in the regulation of hematopoietic pathways and immunological cytokine signaling. The JAK pathway is also involved in tumor cell proliferation and drug resistance in multiple myeloma (MM). Thus,
Autor:
Cathy Wang, Jasper Wang, Zhengyi Yin, Justin Huang, Mingjie Li, David Daniely, Ning Xu, Isabella Nassir, Eric Sanchez, Tara Hekmati, James R. Berenson, Dylan Field, Sean Bujarski, Erin Yu, Nicole Ng, Haiming Chen
Publikováno v:
Blood. 134:4352-4352
Introduction: The JAKSTAT pathway plays a critical role in the regulation of hematopoietic pathways and immunological cytokine signaling. The JAK pathway is also involved in tumor cell proliferation and drug resistance in multiple myeloma (MM). Thus,